drugset / Trial / NCT00002494

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

NCT00002494

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy and alternating regimens of chemotherapy in treating patients who have non-Hodgkin's lymphoma or acute lymphocytic leukemia.

Timeline

Start
1992-05
Primary completion
2004-03
Completion
2006-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified Intravenous
Subject Cytarabine Small molecule Intravenous
Subject Dexamethasone Small molecule Oral
Subject Doxorubicin Other / unclassified Intravenous
Subject Etoposide Small molecule Intravenous
Subject Ifosfamide Small molecule Intravenous
Subject Methotrexate Small molecule Intravenous
Subject Prednisone Other / unclassified Oral
Subject Vincristine Small molecule Intravenous
Background 2-MERCAPTOETHANESULFONIC ACID Small molecule
Background Hydrocortisone Other / unclassified Intrathecal
Background Leucovorin Small molecule Intravenous

Indications